ArticleVirologica Sinica2026

Development and characterization of neutralizing monoclonal antibodies against clinically relevant human adenovirus subgroup B serotypes.

Yuelin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.